Peng Li

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Tyrosine Kinase

Top Venues

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Xi Zhang, Yi Ding, Peng Li, Kirk Bourgeois, Aruna Rangan, Jennifer L Herrick, Animesh D Pardanani, Dong Chen, David Viswanatha, Rong He, Gang Zheng
Null-type SH2B3 mutations are potential drivers in a subset of Ph-negative myeloproliferative neoplasms. American journal of hematology 99 (9) (2024)
Xi Zhang, Yi Ding, Peng Li, Kirk Bourgeois, Aruna Rangan, Jennifer L Herrick, Animesh D Pardanani, Dong Chen, David Viswanatha, Rong He, Gang Zheng
Null-type SH2B3 mutations are potential drivers in a subset of Ph-negative myeloproliferative neoplasms. American journal of hematology (2024)
Mark Kavesh, Maedeh Mohebnasab, Marcela Riveros Angel, Wei Xie, Philipp W Raess, Wei Cui, Richard D Press, Guang Yang, Peng Li
Distinguishing STAT3/STAT5B Mutated Large Granular Lymphocyte Leukemia from Myeloid Neoplasms by Genetic Profiling. Blood advances (2022)
Peng Li, Sara Brown, Margaret Williams, Thomas White, Wei Xie, Wei Cui, Deniz Peker, Li Lei, Christian A Kunder, Huan-You Wang, Sarah S Murray, Jennie Vagher, Tibor Kovacsovics, Jay L Patel
The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms. Blood 140 (7) (2022)
Peng Li, Thomas White, Wei Xie, Wei Cui, Deniz Peker, Gang Zheng, Huan-You Wang, Jennie Vagher, Sara Brown, Margaret Williams, Tibor Kovacsovics, Jay L Patel
AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome. Leukemia (2021)